BACKGROUND AND PURPOSE: To quantify uncertainties in scoring radiation pneumonitis. MATERIALS AND METHODS: Records of 434 patients irradiated for lung cancer from 2000 to 2010 were retrospectively reviewed; IRB-approved study. From these, 121 received ≥ 60 Gy for non-small cell lung cancer (NSCLC) with ≥ 6 months follow-up. Patients where the physicians were uncertain of the diagnosis due to confounding factors were deemed "hard to score". Subgroups were defined based on lung dosimetric parameters, and frequencies in different subgroups were compared via Fisher's exact test. RESULTS: 21/121 of patients were considered to have pneumonitis; median follow 17 months. Of these, 10/21 were "hard to score"; reasons including acute COPD exacerbation, infection, and tumor progression. "Hard to score" pneumonitis was slightly more common in patients with a COPD history (15%) vs. without COPD (4%) (p=0.05); and with a pre-RT FEV1<1.7 L (16%) vs. ≥1.7 L (4%) (p=0.09). Rates of "unambiguous" pneumonitis trended to be non-significantly slightly higher in patients higher mean lung doses, V5, and V30. CONCLUSION: Radiation pneumonitis occurred in 17% of patients undergoing RT for NSCLC; with diagnostic uncertainty in 48% of these. Poor pre-RT pulmonary function increases the rate of "hard to score" pneumonitis. Dosimetric parameters are slightly better related to "unambiguous" than "hard to score" pneumonitis, as expected.
BACKGROUND AND PURPOSE: To quantify uncertainties in scoring radiation pneumonitis. MATERIALS AND METHODS: Records of 434 patients irradiated for lung cancer from 2000 to 2010 were retrospectively reviewed; IRB-approved study. From these, 121 received ≥ 60 Gy for non-small cell lung cancer (NSCLC) with ≥ 6 months follow-up. Patients where the physicians were uncertain of the diagnosis due to confounding factors were deemed "hard to score". Subgroups were defined based on lung dosimetric parameters, and frequencies in different subgroups were compared via Fisher's exact test. RESULTS: 21/121 of patients were considered to have pneumonitis; median follow 17 months. Of these, 10/21 were "hard to score"; reasons including acute COPD exacerbation, infection, and tumor progression. "Hard to score" pneumonitis was slightly more common in patients with a COPD history (15%) vs. without COPD (4%) (p=0.05); and with a pre-RT FEV1<1.7 L (16%) vs. ≥1.7 L (4%) (p=0.09). Rates of "unambiguous" pneumonitis trended to be non-significantly slightly higher in patients higher mean lung doses, V5, and V30. CONCLUSION: Radiation pneumonitis occurred in 17% of patients undergoing RT for NSCLC; with diagnostic uncertainty in 48% of these. Poor pre-RT pulmonary function increases the rate of "hard to score" pneumonitis. Dosimetric parameters are slightly better related to "unambiguous" than "hard to score" pneumonitis, as expected.
Authors: M L Hernando; L B Marks; G C Bentel; S M Zhou; D Hollis; S K Das; M Fan; M T Munley; T D Shafman; M S Anscher; P A Lind Journal: Int J Radiat Oncol Biol Phys Date: 2001-11-01 Impact factor: 7.038
Authors: Lawrence B Marks; Soren M Bentzen; Joseph O Deasy; Feng-Ming Spring Kong; Jeffrey D Bradley; Ivan S Vogelius; Issam El Naqa; Jessica L Hubbs; Joos V Lebesque; Robert D Timmerman; Mary K Martel; Andrew Jackson Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-01 Impact factor: 7.038
Authors: Zafer Kocak; Elizabeth S Evans; Su-Min Zhou; Keith L Miller; Rodney J Folz; Timothy D Shafman; Lawrence B Marks Journal: Int J Radiat Oncol Biol Phys Date: 2005-07-01 Impact factor: 7.038
Authors: L B Marks; M T Munley; G C Bentel; S M Zhou; D Hollis; C Scarfone; G S Sibley; F M Kong; R Jirtle; R Jaszczak; R E Coleman; V Tapson; M Anscher Journal: Int J Radiat Oncol Biol Phys Date: 1997-10-01 Impact factor: 7.038
Authors: M V Graham; J A Purdy; B Emami; W Harms; W Bosch; M A Lockett; C A Perez Journal: Int J Radiat Oncol Biol Phys Date: 1999-09-01 Impact factor: 7.038
Authors: Pehr A Lind; Lawrence B Marks; Donna Hollis; Ming Fan; Su-Min Zhou; Michael T Munley; Timothy D Shafman; Ronald J Jaszczak; R Edward Coleman Journal: Int J Radiat Oncol Biol Phys Date: 2002-10-01 Impact factor: 7.038
Authors: R W Byhardt; C Scott; W T Sause; B Emami; R Komaki; B Fisher; J S Lee; C Lawton Journal: Int J Radiat Oncol Biol Phys Date: 1998-10-01 Impact factor: 7.038
Authors: Alexander N Hanania; Walker Mainwaring; Yohannes T Ghebre; Nicola A Hanania; Michelle Ludwig Journal: Chest Date: 2019-04-15 Impact factor: 9.410
Authors: Justin M Haseltine; Andreas Rimner; Daphna Y Gelblum; Ankit Modh; Kenneth E Rosenzweig; Andrew Jackson; Ellen D Yorke; Abraham J Wu Journal: Pract Radiat Oncol Date: 2015-11-11
Authors: Pegah Jahangiri; Kamyar Pournazari; Drew A Torigian; Thomas J Werner; Samuel Swisher-McClure; Charles B Simone; Abass Alavi Journal: Eur J Nucl Med Mol Imaging Date: 2018-09-18 Impact factor: 9.236
Authors: Mun Sem Liew; Joseph Sia; Maud H W Starmans; Ali Tafreshi; Sam Harris; Malcolm Feigen; Shane White; Allan Zimet; Philippe Lambin; Paul C Boutros; Paul Mitchell; Thomas John Journal: Cancer Med Date: 2013-10-16 Impact factor: 4.452